| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5900569 | Diabetes Research and Clinical Practice | 2007 | 6 Pages |
Abstract
Pioglitazone is modestly effective adjunct to insulin therapy in lean type1 diabetic subjects. It improves post-prandial glucose levels and HbA1c without alterations in body weight and insulin requirement.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
R. Bhat, A. Bhansali, S. Bhadada, R. Sialy,